Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors.

Abstract:

:Cardiovascular (CV) adverse events are considered common complications of ponatinib treatment. Recently, it has been demonstrated that ponatinib dose reductions in definite settings can obtain optimal responses and lower ponatinib-related CV events. In this study, we describe the management of 5 patients with chronic myeloid leukemia treated with ponatinib, from second to fourth line of tyrosine kinase inhibitor therapy, carrying high pre-ponatinib CV risk, who obtained optimal molecular response and developed no CV adverse event during follow-up. Among these 5 patients, 2 had diagnosis of ischemic heart disease and underwent percutaneous angioplasty, 2 had type 2 diabetes and arterial hypertension, and 1 had only arterial hypertension. Median follow-up for ponatinib therapy is 1,039 days (34.6 months). Median dosage administered is 30 mg a day. SCORE charts were used to estimate risk of CV death in 10 years and Charlson Comorbidity Index was applied to estimate age-adjusted risk of death related to comorbidities. Strict cardiologic follow-up (complete evaluation every 3 to 6 months) and maximum effort in the control of CV modifiable risk factors are strongly recommended in the management of ponatinib treatment in patients at high risk for CV events and may allow the use of ponatinib in patients belonging to CV risk category.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Santoro M,Accurso V,Mancuso S,Contrino AD,Sardo M,Novo G,Di Piazza F,Perez A,Russo A,Siragusa S

doi

10.1159/000504664

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

205-209

issue

4

eissn

0009-3157

issn

1421-9794

pii

000504664

journal_volume

64

pub_type

  • Post-antibiotic effects of cefdinir on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyrogenes.

    abstract::The post-antibiotic effects (PAEs) of a new cephalosporin, cefdinir, were determined against a range of organisms using a viable counting technique. Cefdinir exerted considerable PAEs against Staphylococcus aureus and Streptococcus pyogenes, but no overall post-antibiotic inhibition of growth was detected against Esch...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239198

    authors: Howard BM,Pinney RJ,Smith JT

    更新日期:1994-07-01 00:00:00

  • Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes.

    abstract::A rational choice of an antimicrobial agent must take into account not only the activity against the specific pathogen but also any possible negative or positive effects on the host defense system. Rokitamycin (RKM) is an orally active 16-membered-ring macrolide; there are no reports of specific investigations of thes...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239560

    authors: Braga PC,Maci S,Dal Sasso M,Fonti E,Ghessi A

    更新日期:1997-05-01 00:00:00

  • Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiency.

    abstract::The elimination of para-aminosalicylic acid (PAS) after the intravenous injection of 20 mg PAS sodium/kg was estimated in patients with liver disease, in uremic patients and in volunteers without damage of the liver or kidneys. The drug was estimated with a colorimetric and fluorometric method. In the volunteers, the ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000222010

    authors: Held H,Fried F

    更新日期:1977-01-01 00:00:00

  • A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors.

    abstract:BACKGROUND/AIMS:A single-institution phase I trial to determine the feasibility of using filgrastim or pegfilgrastim to increase the dose intensity of biweekly docetaxel and gemcitabine. METHODS:Patients with metastatic solid tumors received gemcitabine 3,000 mg/m(2) and increasing doses of docetaxel (55 mg/m(2) in 10...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000313526

    authors: Dragnev KH,Hardin SB,Pipas JM,Davis TH,Rigas JR

    更新日期:2010-01-01 00:00:00

  • Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

    abstract:BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000305256

    authors: Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

    更新日期:2010-01-01 00:00:00

  • Efficacy of oral administration of ofloxacin in lower respiratory tract infections in aged patients with chronic lung disease.

    abstract::The efficacy of ofloxacin for the treatment of lower respiratory tract infection was evaluated in aged patients with chronic lung disease. Results are the following: improvement of leukocytosis and arterial oxygen tension was observed; peripheral blood cell analysis showed a decrease in natural killer cell counts and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238901

    authors: Yamaoka M,Fukuchi Y,Yokouchi M,Teramoto N,Nagase T,Ishida K,Ohtomo E,Orimo H

    更新日期:1991-01-01 00:00:00

  • Susceptibility of Campylobacter pylori isolated from pediatric and adult patients to seven new quinolone antibiotics and nalidixic acid.

    abstract::The susceptibility of 26 strains of Campylobacter pylori to 7 new quinolone antibiotics and nalidixic acid was determined. All strains were resistant to nalidixic acid. Difloxacin, A-56620, A-62254, and ciprofloxacin were equally effective against the test strains with MICs ranging from 0.06 to 2.0 micrograms/ml. Fler...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238589

    authors: Hupertz V,Carr H,Czinn SJ

    更新日期:1988-01-01 00:00:00

  • Therapeutic activity of pretazettine on Ehrlich ascites carcinoma: adjuvant effect on standard drugs in ABC regimen.

    abstract::A narcissus alkaloid, pretazettine hydrochloride (PTZ), has been shown to be active against Ehrlich ascites carcinoma. The Ehrlich cells are more sensitive to PTZ in DBA/2 mice than in Swiss mice. The therapeutic activity of the individual standard drugs in ABC (adriamycin, BCNU, and cyclophosphamide) regimen against ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237992

    authors: Furusawa E,Lum MK,Furusawa S

    更新日期:1981-01-01 00:00:00

  • Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.

    abstract::The introduction of highly active antiretroviral therapy (HAART) has significantly modified the course of human immunodeficiency virus (HIV) disease, with longer survival and improved quality of life of HIV-infected subjects. However, HAART regimens, especially those including protease inhibitors, have been shown to c...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000093034

    authors: Barbaro G,Barbarini G

    更新日期:2006-01-01 00:00:00

  • Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.

    abstract:BACKGROUND:The purpose of this study was to evaluate the feasibility and compliance of adjuvant chemotherapy of S-1 plus carboplatin for patients with completely resected non-small cell lung cancer (NSCLC) of pathological stage IB-IIIB. METHODS:S-1 was given orally at a dose of 80 mg/m²/day for 2 weeks, followed by a ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000351101

    authors: Komazaki Y,Sakashita H,Furuiye M,Fujie T,Tamaoka M,Sumi Y,Miyazaki Y,Kojima K,Jin Y,Inase N

    更新日期:2013-01-01 00:00:00

  • The pharmacokinetics of new oral cephalosporins in children.

    abstract::Differences in the pharmacokinetic parameters of cephalosporins between children and adults may be predictable on the basis of the level of maturation of the physiologic processes involved in drug disposition. It appears that the most important of these factors (gastrointestinal, renal and hepatic function) are reason...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000239090

    authors: Edwards DJ,Stoeckel K

    更新日期:1992-01-01 00:00:00

  • Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    abstract:BACKGROUNDS:The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma (BTC). However, this is only based on phase II studies performed in selected patients.We assessed the efficacy and safety of the GEMOX regimen in non-selected patients with advanced BTC. MET...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000316848

    authors: Hollebecque A,Bouché O,Romano O,Scaglia E,Cattan S,Zerbib P,Heurgue A,Lagarde S,Mariette C,Triboulet JP,Pruvot FR,Hebbar M

    更新日期:2010-01-01 00:00:00

  • Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilli.

    abstract::The comparative in vitro activity of amikacin, cefamandole, cefoperazone, cefotaxime, cefoxitin, cephalothin, chloramphenicol, moxalactam, piperacillin, ticarcillin and tobramycin against 170 community blood culture isolates of gram-negative bacilli was investigated using the quantitative plate dilution method. Result...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238243

    authors: Gordon RC,Tack KJ,Haddy RI,Fechner L,Wofford R

    更新日期:1984-01-01 00:00:00

  • Methotrexate-loaded polymethylmethacrylate bone cement for local bone metastasis therapy: pilot animal study in the rabbit patellar groove.

    abstract::Local chemotherapy is an option in bone metastasis treatment. On the other hand, evaluation of side effects on bone is a difficult issue in drug development and biomaterials research. Most animal models to date are inappropriate or not feasible. Rabbits are an alternative to other bigger mammals and have an appropriat...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000153315

    authors: Draenert FG,Draenert K

    更新日期:2008-01-01 00:00:00

  • Antibacterial effects of niridazole. I. Effect on infection of mice with Salmonella typhimurium.

    abstract::Niridazole was shown to be an effective chemotherapeutic agent for mice infected intravenously with a niridazole-sensitive strain of Salmonella typhimurium. Death rates as well as bacterial counts per spleen were reduced, even in compromised animals. Histologic examination of spleens proved the reduction of inflammato...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238069

    authors: Hof H,Müller KM,Heine WD

    更新日期:1982-01-01 00:00:00

  • Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration.

    abstract:BACKGROUND:Taxanes cause hypersensitivity reactions, averted by premedication with H1 blockers and high glucocorticoid (GC) doses. Prolonged weekly taxane administration may lead to GC toxicity. PURPOSE:To determine whether patients not hypersensitive to initial paclitaxel (PTX) infusion after high-dose GC premedicati...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000085618

    authors: Braverman AS,Rao S,Salvatti ME,Adamson B,McManus M,Pierre S

    更新日期:2005-05-01 00:00:00

  • In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus.

    abstract::An agar dilution technique was used to determine the MIC of pristinamycin for 124 clinical isolates of methicillin-resistant Staphylococcus aureus. All were inhibited by less than or equal to 0.5 mg/1, quite similar to the sensitivity of a number of methicillin-sensitive strains. MICs obtained using a microdilution me...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238200

    authors: Mutton KJ,Andrew JH

    更新日期:1983-01-01 00:00:00

  • Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients.

    abstract::Cefpirome and six other antimicrobial agents were tested against 884 blood culture isolates from cancer patients. Cefpirome was highly active against aerobic gram-negative bacilli including Acinetobacter spp., and the Enterobacteriaceae. Only imipenem was more active than cefpirome against Pseudomonas aeruginosa. Cefp...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238433

    authors: Rolston K,Alvarez ME,Hoy JF,LeBlanc B,Ho DH,Bodey GP

    更新日期:1986-01-01 00:00:00

  • Pharmacokinetics of flomoxef in mucosal tissue of the middle ear and mastoid following intravenous administration in humans.

    abstract::The pharmacokinetics of flomoxef in serum and in the mucosal tissue of the middle ear and mastoid were studied in 9 patients undergoing tympanoplasties. All patients received 1 g of flomoxef intravenously. Flomoxef levels in serum and in mucosal tissue were determined by a bioassay method. The peak value of mean conce...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238766

    authors: Saito H,Kimura T,Takeda T,Kishimoto S,Oguma T,Shimamura K

    更新日期:1990-01-01 00:00:00

  • Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.

    abstract::The therapeutic efficacy of oral treatment with levofloxacin, ciprofloxacin, and ampicillin on an experimental pneumonia caused by the penicillin-intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations (MICs) of the quinolones are similar was assessed in immunocompetent CBA/J mice. Levofl...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007181

    authors: Ishida Y,Kurosaka Y,Murakami Y,Otani T,Yamaguchi K

    更新日期:1999-05-01 00:00:00

  • Study on tissue concentrations of antibiotics: bacampicillin in gingiva and maxillary bones.

    abstract::21 patients, whose age ranged from 17 to 60 years and who had not been previously treated with antibiotics or other drugs, received bacampicillin as a perioperative prophylaxis for minor operations in the oral cavity. Four oral doses of bacampicillin were administered: each dose of 800 mg every 12 h, and the last dose...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238541

    authors: del Piano M,Nicosia R,Sessa R,Grippaudo G,Lolli R,Monaco B

    更新日期:1988-01-01 00:00:00

  • The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.

    abstract:BACKGROUND:We evaluated the effectiveness of docetaxel or erlotinib in second-line treatment of non-small cell lung cancer (NSCLC) and focused on the impact of predictive factors on the outcome of therapy. METHODS:204 patients with progressive disease after platinum-based therapy were enrolled: 102 received an infusio...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000336143

    authors: Krawczyk P,Kowalski DM,Wojas-Krawczyk K,Mlak R,Jaśkiewicz P,Kucharczyk T,Winiarczyk K,Krzakowski M,Milanowski J

    更新日期:2012-01-01 00:00:00

  • Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.

    abstract:BACKGROUND:Bacterial endotoxin is known to act as a potent trigger of disseminated coagulation and septic shock. During clinical antibiotic treatment, endotoxin may be released from Gram-negative bacteria. It is known that antibiotic classes differ in their ability to induce endotoxin release. AIM:It was the aim of th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000321622

    authors: Trautmann M,Scheibe C,Wellinghausen N,Holst O,Lepper PM

    更新日期:2010-01-01 00:00:00

  • Treatment of experimental chronic osteomyelitis caused by Morganella morganii with mezlocillin and cloxacillin.

    abstract::Mezlocillin was used alone and in combination with cloxacillin in the treatment of chronic experimental osteomyelitis due to Morganella morganii. This combination showed in vitro synergy as measured by the checkerboard technique. A marked inoculum affect was demonstrated in vitro with mezlocillin and the infecting str...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238267

    authors: Norden CW,Shaffer M

    更新日期:1984-01-01 00:00:00

  • Ciprofloxacin in the treatment of malignant external otitis.

    abstract::Malignant external otitis is a serious infection most frequently caused by Pseudomonas aeruginosa. Because of its antipseudomonal activity and good tissue penetration, ciprofloxacin is an antibiotic which should, in theory, be effective in the treatment of this type of infection. Publications on the use of ciprofloxac...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000239315

    authors: Gehanno P

    更新日期:1994-01-01 00:00:00

  • The effect of tinidazole on several ciliates.

    abstract::The effect of tinidazole on several ciliates (Stylonychia muscorum, Stylonychia mytilus, Tetrahymena pyriformis, Vorticella companula) has been studied. There is a very pronounced difference in sensitivity against this drug between the free-living ciliates here investigated and certain parasitic protozoa. A high resis...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237820

    authors: Alonso P

    更新日期:1979-01-01 00:00:00

  • Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.

    abstract::A method is described which may be used to compare the relative activity of beta-lactam antibiotics against gram-negative bacilli. The method offers several important advantages over conventional methods of evaluation of the antibacterial activity of beta-lactam agents: the bacterial inoculum is simply and accurately ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221965

    authors: Greenwood D

    更新日期:1977-01-01 00:00:00

  • Effect of L- and D-lysine on the growth of Ehrlich ascites tumour.

    abstract::Contrary to L-lysine, D-lysine showed no inhibitory effect on growth of Ehrlich ascites tumour cell in in vivo studies. The in vitro studies on the growth of cultured Ehrlich ascites tumour cells showed similar results, namely, the growth of tumour cells was inhibited when cultured in 0.02 or 0.03 M L-lysine; while 0....

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238657

    authors: Choy YM,Fung KP

    更新日期:1989-01-01 00:00:00

  • Effects of platinum antitumor agents on in vitro assays of human antitumor immunity. II. Effects of cis-[Pt(NH3)2Cl2] on spontaneous cell-mediated cytotoxicity.

    abstract::The effects of cis-[Pt(NH3)2Cl2] on the spontaneous cell-mediated cytotoxicity of human lymphoblast cell lines mediated by normal human peripheral blood lymphocytes was investigated. Direct addition of cis-[Pt(NH3)2Cl2], but not its tumor inactive trans isomer, to the in vitro spontaneous cytotoxicity assay resulted i...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237876

    authors: Mally MB,Taylor RC,Callewaert DM

    更新日期:1980-01-01 00:00:00

  • Dose linearity testing of intravenous ofloxacin, a novel gyrase inhibitor.

    abstract::After intravenous bolus injection of single doses of 25, 50, 75 and 100 mg of ofloxacin (HOE 280) to 34 healthy male volunteers, concentrations of unchanged drug were estimated at various times in serum and urine over 32 and 48 h. Ofloxacin concentrations were determined using high-pressure liquid chromatography (HPLC...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238567

    authors: Verho M,Korn A,Badian M,Malerczyk V,Waldhäusl W

    更新日期:1988-01-01 00:00:00